At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories. That it depends thereby less on large names, but on the future potential and whether the market also recognizes these perspectives, was one of its first learnings at the stock exchange.
On these pages, Nico examines current events at listed companies and takes a closer look at companies that are traded under the radar of the market, in addition to well-known securities.
In order to be able to take advantage of speculative opportunities on the stock exchange, Nico not only focuses on a balanced asset allocation of defensive and opportunity-oriented securities, but also on an intact risk management. "In addition to position size and entry in several tranches, investors should also develop a sense of timing and get to know a stock better before investing," says the columnist.
Commented by Nico Popp
Commented by Nico Popp on March 23rd, 2022 | 10:47 CET
Stocks that change the world: TeamViewer, Perimeter Medical, Nordex
When new technology meets the right opportunity, things can go up quickly for companies. One example is the German company TeamViewer, which already had an established remote desktop solution that many users had heard of when the pandemic broke out. When we moved to the home office overnight but had to use software from the office, it made sense to install TeamViewer. Innovative solutions are also meeting with great demand in other industries. We analyze what this means for investors.
Read
Commented by Nico Popp on March 22nd, 2022 | 11:22 CET
In the right place at the right time: BioNTech, Defence Therapeutics, Bayer
For years, the pandemic has kept the world on tenterhooks. Currently, the epidemic is taking a break, at least in the media. But while the world is looking tautly at Ukraine and more and more refugees are arriving in Germany, the Omicron figures are rising once more. In some cases, the incidence in Germany is over 3,000. Although fewer and fewer people are dying, more people than ever are in quarantine. We look at BioNTech, a typical pandemic stock, and present other exciting investments from the healthcare sector.
Read
Commented by Nico Popp on March 21st, 2022 | 11:15 CET
Shares between expropriation and the new era: Barrick Gold, Triumph Gold, Alibaba
Goldman Sachs has always been considered well-informed and well-connected in investor circles. Even if sometimes a little too much is read into the forecasts of the US bankers, investors should take note of them. Currently, Jeff Currie, commodity specialist at Goldman Sachs, assumes a "perfect upswing" for gold. The price target could be USD 2,500. Goldman sees the precious metal as the "currency of last resort" and points to rising ETF purchases and increasing demand from central banks. We take a look at three stocks and their prospects.
Read
Commented by Nico Popp on March 15th, 2022 | 10:56 CET
TUI, Desert Gold, Deutsche Bank: Uncertainty as an investment opportunity
Only less than a week to go before freedom returns - at least superficially. Those who previously perceived medical masks and testing obligations as repression should breathe a sigh of relief from March 20. Then Germany will also have its Freedom Day. Yet while relief is spreading in many parts of Germany, the conflict in Ukraine is coming to a head. After March 20, the threat to freedom in Europe is likely to be greater than during the most heated federal-state rounds of recent years. We analyze the situation and look at three stocks.
Read
Commented by Nico Popp on March 14th, 2022 | 10:17 CET
Mercedes-Benz Group, Phoenix Copper, JinkoSolar: Learning from history
Investors who kept a cool head after the outbreak of the Corona pandemic in March 2020 were able to enjoy high profits in the months that followed. Immediately after the outbreak began, share prices around the world plummeted. The media proclaimed the end of the economy as we know it. While this was partly true, the markets' conclusions were initially wrong. Instead of economic decline, scarcity determined prices - until today. Even now, the markets are painting a gloomy scenario, right up to the apocalypse. It looks as if supply and demand will ultimately determine prices after all. For investors with a sharp focus and clear understanding, this can be an opportunity. We present three shares.
Read
Commented by Nico Popp on March 11th, 2022 | 10:15 CET
Nordex, MAS Gold, Hensoldt: Shares for the new era
Even if the negotiations between Ukraine and Russia inspire hope, regardless of the interim status, much will change in the coming months and years. The civilian power EU must rethink - in many areas. Gas as a transitional technology can hardly be justified after Putin's war of aggression. Putting national security in the hands of NATO, which is largely supported by the United States, also seems risky - after all, Trump is already preparing his election campaign. In the future, the EU and Germany will have to accelerate climate change and push ahead with rearmament. We present three stocks that could benefit.
Read
Commented by Nico Popp on March 10th, 2022 | 05:10 CET
Interview Cardiol Therapeutics: 'We have two potential blockbusters in our portfolio'
In this interview, Cardiol Therapeutics’ President and CEO David Elsley explains the unique selling points of the Company’s lead product, CardiolRx™, an oral cannabidiol formulation pharmaceutically manufactured under cGMP. He explains why the upcoming clinical trials could result in exclusive multi-year distribution agreements, why the financing last November was a good decision, and how major funds from the U.S. currently stand by Cardiol Therapeutics.
Read
Commented by Nico Popp on March 9th, 2022 | 10:06 CET
Is this how Kostolany would invest? BASF, Globex Mining, Gazprom
War only knows losers. On the stock exchange, however, things look a little different. The stock market reflects tomorrow's changes today and ensures the allocation of capital. When money flows from one sector to another, opportunities also arise for investors. Those who bet on the right horse at the right time, win. Those who make the mistake of betting on the high flyers of the past may experience a financial Waterloo.
Read
Commented by Nico Popp on March 8th, 2022 | 06:00 CET
Power Nickel Interview: 'The coming quarters change everything.'
A promising nickel project in Quebec, several gold properties in Canada and Chile, and a license agreement with Teck Resources that could yet provide surprises - Power Nickel's list of activities is long. But the Company is consolidating. As early as the second quarter, historical data is expected to be converted into an updated resource estimate for the flagship NISK project. Shareholders also stand to receive bonus shares later this year. Here is what Terry Lynch, CEO of Power Nickel, has in mind for 2022 and what the Company needs to do to be valued at CAD 800 million instead of CAD 15 million.
Read
Commented by Nico Popp on March 7th, 2022 | 11:54 CET
Linde, dynaCERT, NEL: Time for hydrogen technology
Gas is still flowing from Russia to the West. But the longer the war in Ukraine continues, the more likely it is that even more onerous sanctions will be imposed. In any case, it is clear that the long-term trend is away from Russian gas. Hydrogen suppliers have been profiting for days from the escalation of violence in Ukraine. Transitional technology could also be in demand to reduce fuel consumption and CO2 emissions in equal measure - after all, climate protection must not be neglected despite rising energy prices. We analyze three hydrogen stocks.
Read